MedTrace Logo

Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules

NCT01464814 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2011-11-16

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of the probiotic KE-99 Lactobacillus casei when administered with omega-3 fish oil on probiotic viability, fecal make-up and gastrointestinal (GI) health in healthy adults.

Conditions

  • Signs and Symptoms, Digestive

Interventions

DIETARY_SUPPLEMENT

probiotic plus fish oil capsule

Lactobacillus casei (4B CFU) plus fish oil capsule, T.I.D., for seven (7) days.

DIETARY_SUPPLEMENT

Fish oil capsule

Fish oil capsule, T.I.D., for seven (7) days

Sponsors & Collaborators

  • Nutrition 21, Inc.

    lead INDUSTRY

Principal Investigators

  • David Seiden, MD · Broward Research Group

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01464814 on ClinicalTrials.gov